偉思醫療(688580.SH)首次公開發行1708.67萬股 發行價67.58元/股 7月8日申購
格隆匯7月6日丨偉思醫療(688580.SH)公佈,公司首次公開發行1708.67萬股人民幣普通股並在科創板上市,發行價格為67.58元/股。
本次網下發行申購日與網上申購日同為2020年7月8日(T日),其中網下申購時間為9:30-15:00,網上申購時間為9:30-11:30,13:00-15:00,網上申購代碼為787580。
募集資金擬用於研發中心建設項目、信息化建設項目、康復設備組裝調試項目、營銷服務及品牌建設儲備資金等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.